Suppr超能文献

COPD 患者参加姑息治疗试验的纳入标准:系统评价。

Criteria for Enrollment of Patients With COPD in Palliative Care Trials: A Systematic Review.

机构信息

Division of Pulmonary, Allergy and Critical Care Medicine (N.S.), Emory University School of Medicine, Atlanta, Georgia, USA.

Division of Pulmonary Sciences and Critical Care Medicine (A.V.L.), University of Colorado School of Medicine, Aurora, Colorado, USA.

出版信息

J Pain Symptom Manage. 2024 Jun;67(6):e891-e905. doi: 10.1016/j.jpainsymman.2024.01.028. Epub 2024 Jan 26.

Abstract

CONTEXT

Use of palliative care interventions in chronic obstructive pulmonary disease (COPD) has increased in recent years and inclusion criteria used to identify patients with COPD appropriate for palliative care vary widely. We evaluated the inclusion criteria to identify ways to improve enrollment opportunities for patients with COPD.

OBJECTIVES

To determine inclusion criteria used to select patients with COPD for palliative care trials.

METHODS

A systematic review was conducted to determine criteria used to select patients with COPD for palliative care randomized controlled trials. A narrative synthesis was conducted for all trials.

RESULTS

Inclusion criteria were highly heterogeneous. Most studies (n = 11, 79%) used a combination of criteria to identify patients with COPD. Commonly used criteria included hospitalization for an acute exacerbation of COPD (n = 8, 57%), home supplemental oxygen use (n = 8, 57%), and spirometry values confirming COPD (n = 6, 43%). Three studies (21.4%) used Modified Medical Research Council score and two studies (21%) used physician prognosis or a performance scale.

CONCLUSION

The most common criteria, a hospitalization for acute exacerbation of COPD or supplemental oxygen use at home, both have the benefit of selecting patients who have a higher symptom burden or higher healthcare utilization who might therefore benefit more from palliative care. By describing the landscape and variability of previously used inclusion criteria, this article serves as a resource for clinicians and researchers. Developing a consistent set of inclusion criteria in the future would help generate generalizable results that can be translated into clinical practice to improve the lives of patients with COPD.

PROSPERO REGISTRATION NUMBER

CRD42022306752.

摘要

背景

近年来,在慢性阻塞性肺疾病(COPD)中使用姑息治疗干预措施的情况有所增加,用于识别适合姑息治疗的 COPD 患者的纳入标准差异很大。我们评估了纳入标准,以寻找改善 COPD 患者入组机会的方法。

目的

确定用于识别 COPD 患者接受姑息治疗试验的纳入标准。

方法

进行了系统评价,以确定用于选择 COPD 患者接受姑息治疗随机对照试验的标准。对所有试验进行了叙述性综合分析。

结果

纳入标准高度异质。大多数研究(n=11,79%)使用了多种标准来识别 COPD 患者。常用的标准包括因 COPD 急性加重而住院(n=8,57%)、家庭补充氧气使用(n=8,57%)和确认 COPD 的肺功能检查值(n=6,43%)。三项研究(21.4%)使用了改良医学研究委员会评分,两项研究(21%)使用了医生预后或表现量表。

结论

最常见的标准,即因 COPD 急性加重而住院或在家中使用补充氧气,都有选择症状负担较高或医疗保健利用率较高的患者的好处,这些患者可能因此从姑息治疗中获益更多。通过描述以前使用的纳入标准的情况和可变性,本文为临床医生和研究人员提供了资源。未来制定一套一致的纳入标准将有助于产生可推广的结果,这些结果可以转化为临床实践,以改善 COPD 患者的生活。

PROSPERO 注册号:CRD42022306752。

相似文献

5
Chronic non-invasive ventilation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的慢性无创通气。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD002878. doi: 10.1002/14651858.CD002878.pub3.

本文引用的文献

9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验